960 related articles for article (PubMed ID: 18368051)
1. LNA-mediated microRNA silencing in non-human primates.
Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S
Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.
Elmén J; Lindow M; Silahtaroglu A; Bak M; Christensen M; Lind-Thomsen A; Hedtjärn M; Hansen JB; Hansen HF; Straarup EM; McCullagh K; Kearney P; Kauppinen S
Nucleic Acids Res; 2008 Mar; 36(4):1153-62. PubMed ID: 18158304
[TBL] [Abstract][Full Text] [Related]
3. Targeting of microRNAs for therapeutics.
Stenvang J; Lindow M; Kauppinen S
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1197-200. PubMed ID: 19021524
[TBL] [Abstract][Full Text] [Related]
4. The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
Stenvang J; Silahtaroglu AN; Lindow M; Elmen J; Kauppinen S
Semin Cancer Biol; 2008 Apr; 18(2):89-102. PubMed ID: 18295505
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA silencing in primates: towards development of novel therapeutics.
Petri A; Lindow M; Kauppinen S
Cancer Res; 2009 Jan; 69(2):393-5. PubMed ID: 19147547
[TBL] [Abstract][Full Text] [Related]
6. Silencing of microRNAs in vivo with 'antagomirs'.
Krützfeldt J; Rajewsky N; Braich R; Rajeev KG; Tuschl T; Manoharan M; Stoffel M
Nature; 2005 Dec; 438(7068):685-9. PubMed ID: 16258535
[TBL] [Abstract][Full Text] [Related]
7. An LNA-based loss-of-function assay for micro-RNAs.
Naguibneva I; Ameyar-Zazoua M; Nonne N; Polesskaya A; Ait-Si-Ali S; Groisman R; Souidi M; Pritchard LL; Harel-Bellan A
Biomed Pharmacother; 2006 Nov; 60(9):633-8. PubMed ID: 16962735
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR.
Rottiers V; Obad S; Petri A; McGarrah R; Lindholm MW; Black JC; Sinha S; Goody RJ; Lawrence MS; deLemos AS; Hansen HF; Whittaker S; Henry S; Brookes R; Najafi-Shoushtari SH; Chung RT; Whetstine JR; Gerszten RE; Kauppinen S; Näär AM
Sci Transl Med; 2013 Nov; 5(212):212ra162. PubMed ID: 24259050
[TBL] [Abstract][Full Text] [Related]
10. Detection of microRNAs by Northern blot analyses using LNA probes.
Várallyay E; Burgyán J; Havelda Z
Methods; 2007 Oct; 43(2):140-5. PubMed ID: 17889801
[TBL] [Abstract][Full Text] [Related]
11. Primate microRNAs miR-220 and miR-492 lie within processed pseudogenes.
Devor EJ
J Hered; 2006; 97(2):186-90. PubMed ID: 16489141
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
[TBL] [Abstract][Full Text] [Related]
13. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.
Xia H; Qi Y; Ng SS; Chen X; Li D; Chen S; Ge R; Jiang S; Li G; Chen Y; He ML; Kung HF; Lai L; Lin MC
Brain Res; 2009 May; 1269():158-65. PubMed ID: 19265686
[TBL] [Abstract][Full Text] [Related]
14. LNA-antisense rivals siRNA for gene silencing.
Jepsen JS; Wengel J
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
[TBL] [Abstract][Full Text] [Related]
15. A miRNA signature of prion induced neurodegeneration.
Saba R; Goodman CD; Huzarewich RL; Robertson C; Booth SA
PLoS One; 2008; 3(11):e3652. PubMed ID: 18987751
[TBL] [Abstract][Full Text] [Related]
16. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation.
Wang X; Liu P; Zhu H; Xu Y; Ma C; Dai X; Huang L; Liu Y; Zhang L; Qin C
Brain Res Bull; 2009 Oct; 80(4-5):268-73. PubMed ID: 19683563
[TBL] [Abstract][Full Text] [Related]
17. Target identification of microRNAs expressed highly in human embryonic stem cells.
Li SS; Yu SL; Kao LP; Tsai ZY; Singh S; Chen BZ; Ho BC; Liu YH; Yang PC
J Cell Biochem; 2009 Apr; 106(6):1020-30. PubMed ID: 19229866
[TBL] [Abstract][Full Text] [Related]
18. Efficient and persistent splice switching by systemically delivered LNA oligonucleotides in mice.
Roberts J; Palma E; Sazani P; Ørum H; Cho M; Kole R
Mol Ther; 2006 Oct; 14(4):471-5. PubMed ID: 16854630
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA detection in bone marrow cells by LNA-FISH.
Debernardi S; Dixon-McIver A
Methods Mol Biol; 2010; 667():33-45. PubMed ID: 20827525
[TBL] [Abstract][Full Text] [Related]
20. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
